DSpace university logo mark
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 030 医学部 > 030 紀要 > Acta Medica Nagasakiensia > Volume 60, No. 2 >

A modified application of the luciferase immunoprecipitation systems for detecting antibodies to the G protein-coupled receptors

ファイル 記述 サイズフォーマット
ActMed60_69.pdf2.02 MBAdobe PDF本文ファイル

タイトル: A modified application of the luciferase immunoprecipitation systems for detecting antibodies to the G protein-coupled receptors
著者: Mukaino, Akihiro / Higuchi, Osamu / Nakane, Shunya / Maeda, Yasuhiro / Sakai, Waka / Nakamura, Hideki / Matsuo, Hidenori / Kawakami, Atsushi
発行日: 2016年 1月
出版者: Nagasaki University School of Medicine / 長崎大学医学部
引用: Acta medica Nagasakiensia, 60(2), pp.69-76; 2016
抄録: Background: When multipass transmembrane molecules are located on the cell surface, there may be interaction with not only bioactive molecules but also pathogenic molecules in areas protruding outside the cell. In antibody-mediated autoimmune disorders, it has been found that the autoantibodies occasionally attack membrane molecules on the cell surface, thus causing the disease such as myasthenia gravis. In such cases, highly sensitive autoantibody detection technology is required for early diagnosis. However, autoantibody analysis technology that is specialized for membrane molecules is still under development. Here we demonstrate a novel method for detecting of antibodies against the extracellular portions of multipass transmembrane molecules. Methods: Antibodies for muscarinic acetylcholine receptor type3 (M3R) were detected with two kinds of luciferase immunoprecipitaion systems (LIPS), conventional LIPS (cLIPS) and its modified application, termed modified LIPS (mLIPS). In mLIPS, antibodies against extracellular portions of membrane molecules could be preferentially detected. Results: An antibody to the amino-terminal portion of human M3R was detected with modified LIPS with a high sensitivity. In contrast, an antibody to the carboxyl-terminal portion was not detected with mLIPS, because it did not interact with intracellular portions of M3R in living cells. We also found antibodies for M3R in a patient serum with Sjögren’s syndrome. Conclusion: Our technology has a promising future, and we hope that it will be applied in the analysis of antibodies against a diverse range of multipass transmembrane molecules, including GPCRs.
キーワード: GPCR / LIPS / AChR / luciferase / autoantibody / autoimmune disease
URI: http://hdl.handle.net/10069/36171
ISSN: 00016055
資料タイプ: Departmental Bulletin Paper
原稿種類: publisher
出現コレクション:Volume 60, No. 2

引用URI : http://hdl.handle.net/10069/36171



Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace